NCT01552434 2025-10-14
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
Clinical Trials
23 trialsNCT03885947 2021-05-24
VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies
Icahn School of Medicine at Mount Sinai
Phase 1 Completed
NCT00181220 2020-05-18
Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
Johns Hopkins University
Phase 1 Withdrawn
NCT02520115 2019-08-14
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT01106872 2018-08-10
Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas
University of Iowa
Phase 1 Completed
NCT02648633 2017-05-31
Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
University of Virginia
Phase 1 Terminated
NCT00246103 2017-02-23
Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00437957 2017-02-23
Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Terminated
NCT01204450 2016-12-23
Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
UNC Lineberger Comprehensive Cancer Center
Phase 1 Terminated
NCT01007695 2016-07-20
VAST
University of Utah
Phase 1 Terminated
NCT02761291 2016-05-16
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
Chang Gung Memorial Hospital
Phase 1 Unknown
NCT00996060 2016-01-18
Use of Hydralazine and Valproic Acid in Advanced Solid Tumor Malignancies
New Mexico Cancer Research Alliance
Phase 1 Completed
NCT01861990 2015-05-22
Valproic Acid in Childhood Progressive Brain Tumors
Medical University of South Carolina
Phase 1 Withdrawn
NCT00530907 2015-01-08
Valproic Acid and Bevacizumab in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00107458 2014-08-07
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
Children's Oncology Group
Phase 1 Completed
NCT00079378 2013-09-30
Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00084981 2013-09-30
Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00109824 2013-06-04
Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00529022 2013-02-20
Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00495872 2012-10-18
Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00513162 2012-09-19
Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00496444 2012-08-01
Azacytidine and Valproic Acid in Patients With Advanced Cancers
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00195156 2006-09-14
Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies
Weill Medical College of Cornell University
Phase 1 Terminated